# A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer

> **NCT01611584** · PHASE1 · WITHDRAWN · sponsor: **Dartmouth-Hitchcock Medical Center**

## Conditions studied

- Lung Cancer in Normal and Malignant Tumors

## Interventions

- **DRUG:** ALA-induced Fluorescence

## Key facts

- **NCT ID:** NCT01611584
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-06
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left institution
- **Last updated:** 2014-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01611584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01611584, "A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01611584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*